PrivateAI announces the commencement of public PGPT token trading after receiving strategic funding

FOR IMMEDIATE RELEASE
Singapore, 12 June 2024
– PRIVATEAI (PRIVATEAI.COM), a decentralized AI protocol founded by the innovative entrepreneur Angel Versetti, recognized as one of Forbes' 30 under 30 Global, and led by former executives from Fantom, Filecoin, Dogecoin, and Syscoin, has successfully completed its Strategic Round funding for its token PGPT. The round saw participation from key investors such as Charlie Hu of Bitlayer, DAO Maker, Gains Associates, Dextools Ventures, Connectico Capital, DOGE.ORG, Stone Block Association, 32 Ventures, Lunar Digital Assets, Pinnacle VC, Samara Asset Group, Snova Capital, and Meezan Ventures. Following the completion of the funding round, PrivateAI's native token PGPT was listed on the centralized cryptocurrency exchange Bitget, experiencing an impressive 500% increase in value within the first 24 hours of trading.
PrivateAI has introduced its revolutionary AI-native distributed data platform, aiming to develop the world's first domain-specific Large Language Model (LLM) for the longevity industry. Utilizing a unique knowledge graph architecture to process and structure scientific and research data, PrivateAI creates opportunities for monetization and liquid markets for owners and producers of longevity-related datasets by rewarding them with its tradeable cryptocurrency PGPT. The platform also offers access to valuable data for companies developing Generative AI, Large Language Models, and AI-powered data analytics, facilitating breakthrough discoveries in life extension, commonly referred to as longevity.
Knowledge Graphs empower AI systems to comprehend data within a broader context, enabling critical thinking, context awareness, and semantic analysis. These graphs continuously evolve as a community of scientists, researchers, and data providers contribute to expanding knowledge. PrivateAI's platform serves as the foundation for advancements in AI-based drug discovery, personalized medicine, genomic research, and the analysis of aging processes. Angel Versetti's vision is to harness collective scientific knowledge to enhance human longevity, a crucial step for humanity's future exploration beyond our Solar system and colonization of other planets.
"PrivateAI's overwhelming public round response, coupled with the remarkable growth of PGPT on the first day of trading, demonstrates a strong demand for impactful, transhumanistic AI applications that drive scientific progress. We are excited to lead the way in pioneering use-cases that were once thought to be unattainable." stated Angel Versetti.
PrivateAI is actively collaborating with prominent longevity-focused scientific research communities worldwide, initiating discussions with research groups at Oxford University, where Angel Versetti pursued his MSc in Evidence-Based Healthcare. Additionally, the platform has formed partnerships with Lifespan.io and Aging Research Drug Discovery (ARDD) scientific consortia dedicated to longevity research.
For further inquiries or interviews, please contact:
Angel Versetti
[email protected]
CC
[email protected]
This press release serves as a general overview. Readers are encouraged to conduct their own research before engaging with the company or its services. Bitcoin.com bears no responsibility for any damages or losses resulting from the use of content, goods, or services mentioned in this press release.